GXI logo

Gerresheimer AG Stock Price

XTRA:GXI Community·€993.4m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 23 Fair Values set on narratives written by author

GXI Share Price Performance

€28.76
-53.69 (-65.12%)
70.4% undervalued intrinsic discount
€97.07
Fair Value
€28.76
-53.69 (-65.12%)
71.2% undervalued intrinsic discount
€100.00
Fair Value
Price €28.76
AnalystHighTarget €100.00
AnalystConsensusTarget €63.72
AnalystLowTarget €47.50

GXI Community Narratives

AnalystHighTarget·
Fair Value €97.07 70.4% undervalued intrinsic discount

Secular Trends Will Drive Premium Drug Delivery Packaging Adoption

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystConsensusTarget·
Fair Value €63.72 54.9% undervalued intrinsic discount

New Production Lines In Lohr And Skopje Will Improve Efficiency

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AnalystLowTarget·
Fair Value €47.5 39.5% undervalued intrinsic discount

Rising Production Costs And Regulatory Burdens Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent GXI News & Updates

Why We're Not Concerned About Gerresheimer AG's (ETR:GXI) Share Price

Sep 18
Why We're Not Concerned About Gerresheimer AG's (ETR:GXI) Share Price

Here's Why Gerresheimer (ETR:GXI) Is Weighed Down By Its Debt Load

Jul 31
Here's Why Gerresheimer (ETR:GXI) Is Weighed Down By Its Debt Load

Gerresheimer AG Key Details

€2.3b

Revenue

€1.6b

Cost of Revenue

€605.2m

Gross Profit

€581.8m

Other Expenses

€23.4m

Earnings

Last Reported Earnings
Aug 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.68
Gross Margin
26.89%
Net Profit Margin
1.04%
Debt/Equity Ratio
155.5%

Gerresheimer AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Reasonable growth potential with slight risk.

4 Risks
2 Rewards

About GXI

Founded
1864
Employees
13535
CEO
Dietmar Siemssen
WebsiteView website
www.gerresheimer.com

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. It serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

German Market Performance

  • 7 Days: -1.0%
  • 3 Months: -1.1%
  • 1 Year: 12.4%
  • Year to Date: 12.1%
Over the last 7 days, the market has dropped 1.0%, driven by losses in the Consumer Discretionary and Industrials sectors of 4.0% and 1.8%, respectively. As for the longer term, the market has actually risen by 12% in the last year. As for the next few years, earnings are expected to grow by 17% per annum. Market details ›